Activities of Cytochrome P450 Enzymes in Liver and Kidney Microsomes from Systemic Carnitine Deficiency Mice with a Gene Mutation of Carnitine / Organic Cation Transporter





  Juvenile visceral steatosis (jvs) mice, isolated from the C3H-H-2° strain, exibit a systemic carnitine deficiency (SCD) phenotype and develop fatty liver, hyperammonemia and hypoglycemia. This phenotype is caused by a missense mutation (Leu352Arg) of a sodium-dependent carnitine/organic cation transporter, Octn2 (Slc22a5). The jvs mouse could be a useful model for pharmacokinetics and drug metabolism studies concerning Octn2 substrate drugs. In the present study, the effects of the SCD phenotype on the cytochrome P450 (P450 or CYP) dependent activities of four endobiotic and seven xenobiotic oxidations catalyzed by liver and kidney microsomes from jvs mice were investigated. The <i>jvs</i>-type mutation was genotyped by PCR-RFLP. The contents of total P450 and NADPH-P450 reductase were similar in the the liver microsomes from male or female mice of the wild-type and those heterozygous or homozygous for the <i>jvs</i>-type mutation. The 6β-hydroxylation activities of testosterone and progesterone (marker for Cyp3a) based on the protein contents were 1.2- to 2.0-fold higher in liver microsomes from <i>jvs/jvs</i>-type mice compared to <i>jvs/wt</i>- or <i>wt/wt</i>-type mice. Coumarin 7-hydroxylation activities (marker for Cyp2a) were decreased to 0.7-fold in the male <i>jvs/jvs</i>-type mice. The activities of lauric acid 12-hydroxylation (a marker for Cyp4a) and aniline <i>p</i>-hydroxylation (a marker for Cyp2e1) in liver microsomes were increased 1.4- to 1.9-fold in female <i>jvs/jvs</i>-type mice. Genotoxic activation of 2-aminofluorene (a marker for Cyp4b1) by male and female mouse kidney microsomes were not affected by the SCD phenotype. These results demonstrated that the SCD phenotype affected the P450-dependent catalytic activities in liver microsomes. The jvs mouse could provide valuable information in drug interaction and drug metabolism studies of OCTN2 substrate drugs and new compounds in development.<br>


  • Drug metabolism and pharmacokinetics

    Drug metabolism and pharmacokinetics 17(1), 47-53, 2002-03-29

    The Japanese Society for the Study of Xenobiotics

参考文献:  35件中 1-35件 を表示

被引用文献:  1件中 1-1件 を表示


  • 本文言語コード
  • 資料種別
  • ISSN
  • データ提供元
    CJP書誌  CJP引用  J-STAGE